Neuropeptide Y and its involvement in chronic pain

Marta Diaz-delCastillo; David P D Woldbye; Anne Marie Heegaard

doi:10.1016/j.neuroscience.2017.08.050

Neuropeptide Y and its involvement in chronic pain

Marta Diaz-delCastillo, David P D Woldbye, Anne Marie Heegaard

Neuropharm and Genetics

19 Citationer (Scopus)

Abstract

Chronic pain is a serious condition that significantly impairs the quality of life, affecting an estimate of 1.5 billion people worldwide. Despite the physiological, emotional and financial burden of chronic pain, there is still a lack of efficient treatments. Neuropeptide Y (NPY) is a highly conserved endogenous peptide in the central and peripheral nervous systems of all mammals, which has been implicated in both pro- and antinociceptive effects. NPY is expressed in the superficial laminae of the dorsal horn of the spinal cord, where it appears to mediate its antinociceptive actions via the Y1 and Y2 receptors. Intrathecal administration of NPY in animal models of neuropathic, inflammatory or postoperative pain has been shown to cause analgesia, even though its exact mechanisms are still unclear. It remains to be seen whether these promising central antinociceptive effects of NPY can be transferred into a future treatment for chronic pain.

Originalsprog	Engelsk
Tidsskrift	Neuroscience
Vol/bind	387
Sider (fra-til)	162-169
Antal sider	8
ISSN	0306-4522
DOI	https://doi.org/10.1016/j.neuroscience.2017.08.050
Status	Udgivet - 1 sep. 2018

Adgang til dokumentet

10.1016/j.neuroscience.2017.08.050

https://arxiv.org/ftp/arxiv/papers/1711/1711.08941.pdfLicens: Andet

Citationsformater

@article{2dd09c60b7d7405486b2337a2c3fa34e,

title = "Neuropeptide Y and its involvement in chronic pain",

abstract = "Chronic pain is a serious condition that significantly impairs the quality of life, affecting an estimate of 1.5 billion people worldwide. Despite the physiological, emotional and financial burden of chronic pain, there is still a lack of efficient treatments. Neuropeptide Y (NPY) is a highly conserved endogenous peptide in the central and peripheral nervous systems of all mammals, which has been implicated in both pro- and antinociceptive effects. NPY is expressed in the superficial laminae of the dorsal horn of the spinal cord, where it appears to mediate its antinociceptive actions via the Y1 and Y2 receptors. Intrathecal administration of NPY in animal models of neuropathic, inflammatory or postoperative pain has been shown to cause analgesia, even though its exact mechanisms are still unclear. It remains to be seen whether these promising central antinociceptive effects of NPY can be transferred into a future treatment for chronic pain.",

keywords = "Journal Article",

author = "Marta Diaz-delCastillo and Woldbye, {David P D} and Heegaard, {Anne Marie}",

year = "2018",

month = sep,

day = "1",

doi = "10.1016/j.neuroscience.2017.08.050",

language = "English",

volume = "387",

pages = "162--169",

journal = "Neuroscience",

issn = "0306-4522",

publisher = "Pergamon Press",

}

TY - JOUR

T1 - Neuropeptide Y and its involvement in chronic pain

AU - Diaz-delCastillo, Marta

AU - Woldbye, David P D

AU - Heegaard, Anne Marie

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Chronic pain is a serious condition that significantly impairs the quality of life, affecting an estimate of 1.5 billion people worldwide. Despite the physiological, emotional and financial burden of chronic pain, there is still a lack of efficient treatments. Neuropeptide Y (NPY) is a highly conserved endogenous peptide in the central and peripheral nervous systems of all mammals, which has been implicated in both pro- and antinociceptive effects. NPY is expressed in the superficial laminae of the dorsal horn of the spinal cord, where it appears to mediate its antinociceptive actions via the Y1 and Y2 receptors. Intrathecal administration of NPY in animal models of neuropathic, inflammatory or postoperative pain has been shown to cause analgesia, even though its exact mechanisms are still unclear. It remains to be seen whether these promising central antinociceptive effects of NPY can be transferred into a future treatment for chronic pain.

AB - Chronic pain is a serious condition that significantly impairs the quality of life, affecting an estimate of 1.5 billion people worldwide. Despite the physiological, emotional and financial burden of chronic pain, there is still a lack of efficient treatments. Neuropeptide Y (NPY) is a highly conserved endogenous peptide in the central and peripheral nervous systems of all mammals, which has been implicated in both pro- and antinociceptive effects. NPY is expressed in the superficial laminae of the dorsal horn of the spinal cord, where it appears to mediate its antinociceptive actions via the Y1 and Y2 receptors. Intrathecal administration of NPY in animal models of neuropathic, inflammatory or postoperative pain has been shown to cause analgesia, even though its exact mechanisms are still unclear. It remains to be seen whether these promising central antinociceptive effects of NPY can be transferred into a future treatment for chronic pain.

KW - Journal Article

U2 - 10.1016/j.neuroscience.2017.08.050

DO - 10.1016/j.neuroscience.2017.08.050

M3 - Review

C2 - 28890052

SN - 0306-4522

VL - 387

SP - 162

EP - 169

JO - Neuroscience

JF - Neuroscience

ER -

Neuropeptide Y and its involvement in chronic pain

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater